Neurotech International Limited (ASX:NTI)
Australia · Delayed Price · Currency is AUD 0.0160
-0.0010 (-5.88%)
Aug 5, 2025, 3:08 PM AEST
MorphoSys AG Market Cap
Neurotech International has a market cap or net worth of 17.84 million as of August 4, 2025. Its market cap has decreased by -77.80% in one year.
Market Cap
17.84M
Enterprise Value
11.88M
Revenue
80.48K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since November 4, 2016, Neurotech International's market cap has decreased from 25.09M to 17.84M, a decrease of -28.88%. That is a compound annual growth rate of -3.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 19.94M | -65.21% |
| Dec 31, 2024 | 57.32M | -6.85% |
| Dec 29, 2023 | 61.53M | 8.18% |
| Dec 29, 2022 | 56.88M | 35.96% |
| Dec 31, 2021 | 41.83M | 65.70% |
| Dec 31, 2020 | 25.25M | 1,062.42% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 127.86B |
| Pro Medicus | 32.80B |
| Cochlear | 20.43B |
| Sonic Healthcare | 13.51B |
| Ramsay Health Care | 8.74B |
| Telix Pharmaceuticals | 6.82B |
| Ansell | 4.35B |
| Mesoblast | 3.01B |